Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
2.50
Ask:
2.91
Spread: 0.41 (16.40%)
Market Cap: £4.56m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Form 8 (OPD) Nanoco Group Plc

5 Nov 2019 15:36

Investec Asset Management Limited - Form 8 (OPD) Nanoco Group Plc

Investec Asset Management Limited - Form 8 (OPD) Nanoco Group Plc

PR Newswire

London, November 5

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Investec Asset Management Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNanoco Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: No
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 04 November 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Common Stock GBP.1
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:3,904,1671.36%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:3,904,1671.36%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:05 November 2019
Contact name:Ian Gartshore
Telephone number:02075971825

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Aug 20127:00 amRNSTotal Voting Rights
31st Jul 20127:00 amRNSSigns Joint Development Agreement
27th Jul 20127:00 amRNSExercise of Options
25th Jun 20127:00 amRNSChange of Adviser
9th May 20127:00 amRNSAchieves US$2m Milestone
2nd Apr 20122:15 pmRNSTotal Voting Rights
28th Mar 20127:00 amRNSExercise of Options
26th Mar 20127:00 amRNSInterim Results
14th Feb 20127:00 amRNSSigns Joint Development Agreement
10th Feb 20128:56 amRNSHolding(s) in Company
7th Feb 20128:58 amRNSHolding(s) in Company
7th Feb 20128:55 amRNSHolding(s) in Company
31st Jan 20127:00 amRNSAchieves US$1m Milestone
25th Jan 20124:40 pmRNSSecond Price Monitoring Extn
25th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20124:40 pmRNSSecond Price Monitoring Extn
20th Jan 20124:35 pmRNSPrice Monitoring Extension
20th Jan 20127:00 amRNSNotification of Results
13th Jan 20124:35 pmRNSPrice Monitoring Extension
16th Dec 201111:12 amRNSResult of AGM
16th Dec 20117:00 amRNSAGM Statement
6th Dec 201111:16 amRNSTotal Voting Rights - Voting Rights and Capital
29th Nov 20114:21 pmRNSHolding(s) in Company
29th Nov 20117:00 amRNSGrant of Options and Directors' Dealings
22nd Nov 20117:00 amRNSDirector/PDMR Shareholding
16th Nov 20117:00 amRNSAnnual Report & Accounts
15th Nov 20112:49 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSPreliminary Results
3rd Oct 20117:00 amRNSTokyo Electron
9th Sep 20117:00 amRNSNotification of Results
15th Aug 20118:21 amRNSHolding(s) in Company
12th Aug 20117:00 amRNSJoint Development Agreement
28th Jul 20117:00 amRNSAppointment of Nomad
15th Jul 20114:22 pmRNSHolding(s) in Company
30th Jun 20117:00 amRNSApplication for Admission
3rd Jun 20117:00 amRNSDirector/PDMR Shareholding
27th May 201110:53 amRNSIssue of Equity
5th Apr 20117:00 amRNSDevelopment Agreement
4th Apr 20117:00 amRNSInterim Results
1st Apr 20117:00 amRNSAchieves US$2m Milestone
25th Mar 20119:50 amRNSHolding(s) in Company
10th Feb 20117:00 amRNSNotification of Interim Results
7th Feb 20114:33 pmRNSHolding(s) in Company
4th Feb 20114:35 pmRNSHolding(s) in Company
28th Jan 20117:00 amRNSPlacing Raises £15 million
27th Jan 20113:01 pmRNSProposed Placing
27th Jan 20113:00 pmRNSRuncorn Commissioning
14th Jan 20113:18 pmRNSIssue of Equity
17th Dec 20107:00 amRNSMilestone Payment
10th Dec 201011:51 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.